C
Hepatic triglyceride content
Lipids & LipoproteinsLab test / biomarkerriskmodifiable
8
evidence score
Also known as: hepatic triglycerides, triglyceride content in the liver
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 3meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Diabetes mellitus and macrovascular disease: mechanisms and mediators. — The American journal of medicine 2007 · PMID 17826041
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT04675255 | WU 360: Assessing the Impact of Integrase Strand Transfer Inhibitors (INSTI) to Protease Inhibitor (PI) Switch on Insulin Sensitivity and Fat Metabolism (ADIPOSITY): a Sub-study of DEFINE | COMPLETED | INTERVENTIONAL | Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose tissue biopsy, MRI scan to assess intrahepatic triglyceride content |
| NCT01041677 | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-Center Study to Evaluate the Effect of JNJ-16269110 on Hepatic Triglyceride Content in Obese Subjects | COMPLETED | INTERVENTIONAL | R256918, placebo, R256918 |
Genetic associations (0)
None linked.